Cardiff Oncology’s (CRDF) Outperform Rating Reiterated at William Blair
William Blair reiterated their outperform rating on shares of Cardiff Oncology (NASDAQ:CRDF – Free Report) in a report released on Wednesday morning,RTT News reports. Separately, HC Wainwright boosted their target price on Cardiff Oncology from $17.00 to $18.00 and gave the stock a “buy” rating in a report on Friday, May 9th. Read Our Latest […]
William Blair reiterated their outperform rating on shares of Cardiff Oncology (NASDAQ:CRDF – Free Report) in a report released on Wednesday morning,RTT News reports. Separately, HC Wainwright boosted their target price on Cardiff Oncology from $17.00 to $18.00 and gave the stock a “buy” rating in a report on Friday, May 9th. Read Our Latest […]
